Influence of hypertonic saline solution infusion on defibrillation efficacy

Chest

Volumn 110, Issue 3, 1996, Pages 784-790

  Ujhellyi, Michael R ^a,b   Winecoff, Allision P ^a   Schur, Michael ^b   Frede, Thomas ^c   Bottorff, Michael B ^b   Gabel, Marjorie ^c   Markel, Michael L ^c  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^c College of Medicine ^*

Author keywords

cardiac electrophysiology; hypertonic saline solution; ion conductance; ventricular defibrillation; ventricular fibrillation

Indexed keywords

CALCIUM ION; GLUCOSE; SODIUM; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEFIBRILLATION; HEART MUSCLE POTENTIAL; HEART MUSCLE REFRACTORY PERIOD; HEART VENTRICLE CONDUCTION; HEART VENTRICLE FIBRILLATION; NONHUMAN; PRIORITY JOURNAL; SWINE;

EID: 0030479823     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.110.3.784     Document Type: Article

References (32)

1. Ujhelyi MR, O'Rangers EA, Chow MSS, et al. Defibrillation energy requirements during moricizine and combination antiarrhythmic therapy. J Cardiovasc Pharmacol 1992; 20:932-39
2. Echt DS, Black JN, Barbey JT, et al. Evaluation of antiarrhythmic drugs on defibrillation energy requirements in dogs. Circulation 1989; 79:1106-17
3. Chow MSS, Kluger J, Lawrence R, et al. The effect of lidocaine and bretylium on the defibrillation threshold during cardiac arrest and cardiopulmonary resuscitation. Proc Soc Exp Biol Med 1986; 182:63-7
4. Ujhelyi MR, Schur M, Frede T, et al. Differential effects of lidocaine on defibrillation threshold and monophasic versus biphasic shock waveforms. Circulation 1995; 92:1644-50
5. Ujhelyi MR, Schur M, Frede T, et al. Mechanisms of antiarrhythmic drug-induced changes in defibrillation threshold: Role of potassium and sodium channel conductance. J Am Coll Cardiol 1996; 27:1534-42
6. Dorian P, Wang M, David I, et al. Oral clofilium produces sustained lowering of defibrillation energy requirements in a canine model. Circulation 1991; 83:614-21
7. Fain ES, Dorian P, Davy JM, et al. Effects of encainide and its metabolites on energy requirements for defibrillation. Circulation 1986; 7:397-405
8. Hernandez R, Mann DE, Breckinridge S, et al. Effects of flecainide on defibrillation thresholds in the anesthetized dog. J Am Coll Cardiol 1989; 14:777-81
9. +]o. Pflugers Arch 1982; 392:379-87
10. Sasyniuk BI, Jhamandas V. Mechanisms of reversal of toxic effects of amitriptyline on cardiac Purkinje fibers by sodium bicarbonate. J Pharmacol Exp Ther 1984; 231:387-94
11. Turgeon J. Wisialowski TA, Wong W, et al. Suppression of longitudinal versus transverse conduction by sodium channel block: effects of sodium bolus. Circulation 1992; 85:2221-26
12. Bajaj AK, Woosley RL, Roden DM. Acute electrophysiologic effects of sodium administration in dogs treated with o-desmethyl encainide. Circulation 1989; 80:994-1002
13. Pentel PR, Fifield J, Salerno DM. Lack of effect of hypertonic sodium bicarbonate on QRS duration in patients taking therapeutic doses of class IC antiarrhythmic drugs. J Clin Pharmacol 1990; 30:789-94
14. Haigney MCP, Lakatta EG, Stern MD, et al. Sodium channel blockade reduces hypoxic loading and sodium-dependent calcium loading. Circulation 1994; 90:391-99
15. Schrader R, Brooks M, Echt DS. Effects of verapamil and Bay K 8644 on defibrillation energy requirements in dogs. J Cardiovasc Pharmacol 1992; 19:839-49
16. Jones DL, Kim YH, Natale A, et al. Bretylium decreases and verapamil increases defibrillation threshold in pigs. PACE 1994; 17:1380-90
17. Babbs CF. Effect of pentobarbital anesthesia on ventricular defibrillation threshold in dogs. Am Heart J 1978; 95:331-37
18. Ujhelyi MR, Schur M, Frede T, et al. Differential effects of lidocaine on defibrillation threshold with monophasic versus biphasic shock waveforms. Circulation 1995; 92:1644-50
19. Harada K, Franklin A, Johnson RG, et al. Acidemia and hypernatremia enhance postischemic recovery of excitation-contraction coupling. Circ Res 1994; 74:1197-1209
20. Ujhelyi MR, Schur M, Frede T, et al. Relationship between defibrillation threshold and changes in ventricular conduction velocity and action potential duration. Fed Am Soc Exp Biol 1995; 9:A605
21. Dorian P, Witkowski FX, Penkoske PA, et al. Barium decreases defibirillation energy requirements. J Cardiovasc Pharmacol 1994; 23:107-12
22. Kroll MW, Anderson KM, Supino CG, et al. Decline in defibrillation thresholds. PACE 1993; 16:213-17
23. Fogoros RN. Amiodarone-induced refractoriness to cardioversion. Ann Intern Med 1984; 100:699-700
24. Marinchak RA, Friehling TD, Kline RA. et al. Effect of antiarrhythmic drugs on defibrillation threshold: case report of an adverse effect of mexiletine and review of the literature. PACE 1988; 11:7-12
25. Guarnieri T, Tomaselli G, Griffith LSC, et al. The interaction of antiarrhythmic drugs and the energy for cardioversion of chronic atrial fibrillation. PACE 1991; 14:1007-12
26. Tworek DA, Nazari J, Ezri M, et al. Interference by antiarrhythmic agents with function of electrical cardiac devices. Clin Pharmol 1992; 11:48-56
27. Frame LH. The effect of chronic oral and acute intravenous amiodarone administration on ventricular defibrillation threshold using implanted electrodes in dogs. PACE 1989; 12:339-46
28. Fogoros RN, Anderson KP, Winkle RA, et al. Amiodarone: clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmias. Circulation 1983; 68:88-94
29. Guldal M, Karaoguz R, Akalin H, et al. Is there an effect of amiodarone on the defibrillation threshold. Jpn Heart J 1993; 34:221-26
30. Jung W, Manz M, Pfeiffer D, et al. Effects of antiarrhythmic drugs on epicardial defibrillation energy-requirements and the rate of defibrillator discharges. PACE 1993; 16:198-201
31. Echt DS, Gremillion ST, Lee JT, et al. Effects of procainamide and lidocaine on defibrillation energy requirements in patients receiving implantable cardioverter defibrillator devices. J Cardiovasc Electrophysiol 1994; 5:752-60
32. Epstein AE, Ellenbogen KA, Kirk KA, et al. Clinical characteristics and outcome of patients with high defibrillation thresholds: a multicenter study. Circulation 1992; 86:1206-16